Ren Luo

1.1k total citations
46 papers, 825 citations indexed

About

Ren Luo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Ren Luo has authored 46 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Nephrology. Recurrent topics in Ren Luo's work include Cardiovascular Health and Risk Factors (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Lung Cancer Research Studies (4 papers). Ren Luo is often cited by papers focused on Cardiovascular Health and Risk Factors (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Lung Cancer Research Studies (4 papers). Ren Luo collaborates with scholars based in China, Hong Kong and United States. Ren Luo's co-authors include Ya Xiao, Xiaoshan Zhao, Xiaomin Sun, Xiaoshan Zhao, Jing-Ru C. Cheng, Jianlu Bi, Xiaoli Nie, Fei Li, Shengwei Wu and Jieyu Chen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Ren Luo

44 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ren Luo China 16 254 133 115 101 94 46 825
Ya Xiao China 14 134 0.5× 130 1.0× 116 1.0× 79 0.8× 62 0.7× 46 632
Wenjing Zhao China 16 300 1.2× 116 0.9× 150 1.3× 81 0.8× 60 0.6× 64 1.1k
Ching‐Chu Chen Taiwan 16 224 0.9× 109 0.8× 32 0.3× 104 1.0× 31 0.3× 50 812
Zheng Yang China 22 351 1.4× 147 1.1× 44 0.4× 77 0.8× 47 0.5× 71 1.4k
Heidemarie Abrahamian Austria 16 209 0.8× 402 3.0× 181 1.6× 51 0.5× 58 0.6× 50 1.4k
Jun Cheng China 16 284 1.1× 290 2.2× 77 0.7× 66 0.7× 52 0.6× 36 855
Qing Wan China 17 228 0.9× 193 1.5× 45 0.4× 138 1.4× 154 1.6× 56 848
Liyuan Han China 14 212 0.8× 152 1.1× 37 0.3× 148 1.5× 41 0.4× 39 1.2k
Filippo Giorgio Di Girolamo Italy 16 88 0.3× 105 0.8× 51 0.4× 82 0.8× 68 0.7× 41 1.0k

Countries citing papers authored by Ren Luo

Since Specialization
Citations

This map shows the geographic impact of Ren Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Luo more than expected).

Fields of papers citing papers by Ren Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Luo. The network helps show where Ren Luo may publish in the future.

Co-authorship network of co-authors of Ren Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ren Luo. A scholar is included among the top collaborators of Ren Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren Luo. Ren Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xue, Zhichao Xing, Xiaoxi Yu, et al.. (2025). Comparative effectiveness for early-stage NSCLC without lymph node involvement based on prospective studies. International Journal of Surgery. 111(8). 5535–5548.
2.
Zheng, Yue, Pengfei Zhou, Hui Wang, et al.. (2025). Stimulator of Interferon Genes Agonist Synergistically Amplifies Programmed Cell Death Protein-1 Blockade and Radiation-Induced Systemic Antitumor Responses via Tumor Microenvironment Enrichment. International Journal of Radiation Oncology*Biology*Physics. 123(2). 536–549. 1 indexed citations
3.
Yao, Zhuoran, et al.. (2025). Dynamic evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy. Journal of Translational Medicine. 23(1). 453–453. 2 indexed citations
4.
Yang, Yuqi, Yijun Wu, Kai Kang, et al.. (2024). Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study. Annals of Hematology. 103(10). 4211–4222. 2 indexed citations
5.
Wang, Zhitao, et al.. (2024). Uptake of biosimilars in China: a retrospective analysis of the case of trastuzumab from 2018 to 2023. Global Health Research and Policy. 9(1). 42–42. 1 indexed citations
6.
Luo, Ren, Xi Rao, Xuanwei Zhang, et al.. (2024). Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models. Theranostics. 14(6). 2573–2588. 8 indexed citations
7.
8.
9.
Cheng, Jing-Ru C., Fei Li, Jieyu Chen, et al.. (2021). Association of stress management skills and stressful life events with allergy risk: a case-control study in southern China. BMC Public Health. 21(1). 1279–1279. 1 indexed citations
10.
Bi, Jianlu, Jing Chen, Xiaomin Sun, et al.. (2019). The development and evaluation of a sub-health self-rating scale for university students in China. BMC Public Health. 19(1). 330–330. 12 indexed citations
11.
Ma, Fei, et al.. (2018). Renoprotective Effect of a Chinese Herbal Formula, Qidan Dihuang Decoction, on Streptozotocin‐Induced Diabetes in Rat. Evidence-based Complementary and Alternative Medicine. 2018(1). 7321086–7321086. 11 indexed citations
12.
Chen, Jieyu, Jianlu Bi, Fei Li, et al.. (2018). Qi‐Deficiency Related Increases in Disease Susceptibility Are Potentially Mediated by the Intestinal Microbiota. Evidence-based Complementary and Alternative Medicine. 2018(1). 1304397–1304397. 12 indexed citations
13.
Sun, Huiying, Zhenyu Jia, Lin Zhong, et al.. (2017). Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma. Oncogene. 36(21). 2957–2968. 63 indexed citations
14.
Chen, Jieyu, Jing-Ru C. Cheng, Yanyan Liu, et al.. (2014). Associations between breakfast eating habits and health-promoting lifestyle, suboptimal health status in Southern China: a population based, cross sectional study. Journal of Translational Medicine. 12(1). 348–348. 59 indexed citations
15.
Bi, Jianlu, Ying Huang, Ya Xiao, et al.. (2014). Association of lifestyle factors and suboptimal health status: a cross-sectional study of Chinese students. BMJ Open. 4(6). e005156–e005156. 72 indexed citations
16.
Ouyang, Mingzi, Yanyan Liu, Wei Tan, et al.. (2014). Bu-Zhong-Yi-Qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model. BMC Complementary and Alternative Medicine. 14(1). 497–497. 22 indexed citations
17.
Chen, Fengsheng, Shenglan Gao, Daniel P. Hollern, et al.. (2014). Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. Cell Death and Disease. 5(5). e1242–e1242. 2 indexed citations
18.
Zhang, Fang Fang, et al.. (2011). Fluorofenidone Attenuates Diabetic Nephropathy and Kidney Fibrosis in <i>db/db</i> Mice. Pharmacology. 88(1-2). 88–99. 30 indexed citations
19.
Zhou, Wenbo, Changxuan You, Hong Zheng, et al.. (2005). An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity. Vaccine. 24(10). 1615–1624. 12 indexed citations
20.
Zhou, Lin, Yaoming Xue, Ren Luo, & Fang Gao. (2002). [Association of insertion/deletion polymorphism in angiotensin-converting enzyme gene with hypertensive type 2 diabetes mellitus].. PubMed. 22(9). 808–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ya Xiao Breakdown of academic impact, for papers by Wenjing Zhao Breakdown of academic impact, for papers by Ching‐Chu Chen Breakdown of academic impact, for papers by Zheng Yang Breakdown of academic impact, for papers by Heidemarie Abrahamian Breakdown of academic impact, for papers by Jun Cheng Breakdown of academic impact, for papers by Qing Wan Breakdown of academic impact, for papers by Liyuan Han Breakdown of academic impact, for papers by Filippo Giorgio Di Girolamo
Rankless by CCL
2026